AAWH · Ascend Wellness Holdings, Inc. · Financials
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| $488.33M | $500.58M | $561.6M | $518.59M | $405.93M | $332.38M | $143.73M | $12.03M | |
| $309.23M | $330.9M | $377.39M | $363.47M | $271.36M | $196.41M | $82.82M | $8.74M | |
| $179.1M | $169.68M | $184.21M | $155.12M | $134.56M | $135.97M | $60.91M | $3.29M | |
| — | 33.9% | 32.8% | 29.91% | 33.15% | 40.91% | 42.38% | 27.33% | |
| $172.77M | $169.69M | $179.48M | $158.74M | $137.09M | $116.67M | $53.07M | $29.41M | |
| $30.39M | $30.16M | $27.1M | $23.59M | $9.82M | $6.75M | $7.53M | $2.07M | |
| $74.7M | $73.53M | $66.16M | $58.98M | $37.11M | $22.22M | $12.56M | $4.1M | |
| — | $186.69M | $179.48M | $158.74M | $142.09M | $153.18M | $53.07M | $29.41M | |
| -$10.67M | -$17.01M | $4.73M | -$3.62M | -$7.53M | -$17.2M | $7.85M | -$26.12M | |
| — | -3.4% | 0.84% | -0.7% | -1.85% | -5.18% | 5.46% | -217.1% | |
| $64.03M | $56.52M | $70.89M | $55.36M | $29.58M | $5.02M | $20.41M | -$22.02M | |
| $69.1M | $51.29M | $45.26M | $36.98M | $32.44M | $63.99M | $12.99M | $6.48M | |
| -$68.46M | -$49.8M | -$44.56M | -$11.14M | -$31.68M | -$63.73M | -$12.99M | -$6.45M | |
| -$79.13M | -$66.82M | -$39.82M | -$14.76M | -$39.21M | -$80.94M | -$5.14M | -$32.58M | |
| $34.7M | $51.38M | $45.17M | $33.45M | $41.69M | $41.72M | $18.7M | $667K | |
| -$113.83M | -$118.19M | -$84.99M | -$48.21M | -$80.9M | -$122.66M | -$25.44M | -$31.9M | |
| — | -23.61% | -15.13% | -9.3% | -19.93% | -36.9% | -17.7% | -265.08% | |
| — | — | — | — | $0 | $0 | $1.6M | -$1.35M | |
| USD/shares | -$0.57 | -$0.58 | -$0.40 | -$0.24 | -$0.44 | -$0.82 | -$0.27 | -$0.37 |
| USD/shares | -$0.57 | -$0.58 | -$0.40 | -$0.24 | -$0.44 | -$0.82 | -$0.27 | -$0.37 |
| shares | — | 203.48M | 212.43M | 199.15M | 183.38M | 149.43M | 95.17M | 87.29M |
| shares | — | 203.48M | 212.43M | 199.15M | 183.38M | 149.43M | 95.17M | — |
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 47 similar-size Drug Manufacturers - Specialty & Generic companies (of 100 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Retail | $339,563,000 | $372,237,000 | $371,172,000 | $305,935,000 | $231,930,000 | $103,859,000 | $11,204,000 |
| Third Party Wholesale | $161,018,000 | $189,362,000 | $147,418,000 | $99,991,000 | — | — | — |
| Wholesale | — | — | — | — | $148,483,000 | $57,452,000 | $1,970,000 |